[The APO A/APO B ratio in the screening of patients at cardiovascular risk].
A brief introduction on the pathogenesis of atherosclerosis is followed by a review of the various tests used in screening subjects at cardiovascular risk including the new test to determine Apo A/Apo B measurement. The reliability of the various biohumoral indices in several sample groups is analysed and compared. It is concluded that variations in the Apo A/Apo B ratio are the most reliable indicator of patients at risk of heart disease.
D001053:Apolipoproteins / Q000097:blood; D001054:Apolipoproteins A; D001055:Apolipoproteins B; D002318:Cardiovascular Diseases / Q000097:blood*; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL; D006801:Humans; D008075:Lipoproteins, HDL / Q000097:blood; D011379:Prognosis; D012306:Risk; D014280:Triglycerides / Q000097:blood
D001053:Apolipoproteins; D001054:Apolipoproteins A; D001055:Apolipoproteins B; D008076:Cholesterol, HDL; D008075:Lipoproteins, HDL; D014280:Triglycerides; D002784:Cholesterol
Il rapporto Apo A/Apo B nello screening dei soggetti a rischio cardiovascolare.